Biomarker changes during acute heart failure treatment

Congestive Heart Failure, 05/04/2012

In this preliminary study, patients with ADHF had measurable changes in MR–proANP, MR–proADM, and CT–pro–ET–1 24 hours after initial therapy. A study of association with clinical course and outcomes to determine the role of these markers in risk–stratification is warranted.

Print Article Summary Cat 2 CME Report